FDA Inspection 999388 — ImpactLife
The FDA completed an inspection of ImpactLife on Jan 18, 2017 in Mattoon, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mattoon, IL (United States)